Identification |
Name: | 2,5-Methano-5H,9H-pyrimido[2,1-b][1,5,3]dioxazepin-9-one,3-[(benzoyloxy)methyl]-2,3-dihydro-8-methyl-, (2R,3R,5R)- |
Synonyms: | 2,5-Methano-5H,9H-pyrimido[2,1-b][1,5,3]dioxazepin-9-one,3-[(benzoyloxy)methyl]-2,3-dihydro-8-methyl-, [2R-(2a,3b,5a)]-;2,3'-Anhydro-5'-O-benzoylthymidine; 5'-O-Benzoyl-2,3'-anhydrothymidine |
CAS: | 70838-44-7 |
Molecular Formula: | C17H16 N2 O5 |
Molecular Weight: | 328.31934 |
InChI: | InChI=1S/C17H16N2O5/c1-10-8-19-14-7-12(24-17(19)18-15(10)20)13(23-14)9-22-16(21)11-5-3-2-4-6-11/h2-6,8,12-14H,7,9H2,1H3 |
Molecular Structure: |
|
Properties |
Density: | 1.45 g/cm3 |
Refractive index: | 1.679 |
Water Solubility: | at 25 deg C (mg/L): 569.3 |
Solubility: | at 25 deg C (mg/L): 569.3 |
Appearance: | Colourless solid |
Specification: | Colourless solid usageEng:An intermediate in the preparation of anti-HIV pharmaceuticals |
Usage: | An intermediate in the preparation of anti-HIV pharmaceuticals |
Safety Data |
|
|